Overview
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-01-01
2024-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aims to assess the effect and breakdown of lysine administration, specifically examining whether it leads to increased plasma 2-AAA in healthy humans.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Vanderbilt University Medical Center
Criteria
Inclusion Criteria:-Prior participant in 2-AAA Dietary study.
Exclusion Criteria:
- Newly diagnosed disease, including cardiovascular, renal, liver disease, or Diabetes
mellitus.
- Individuals who are pregnant or lactating.
- Inability to provide written or electronic informed consent.
- Inability to fast for 8 hours.